Mark Kaplan is a Ph.D. Translational Scientist with over 20 years of experience in drug discovery and development, specializing in large and small molecules as well as oligonucleotides. Currently serving as the Senior Director, Lymphoma Disease Head in Translational Medicine at Bristol Myers Squibb, Kaplan is recognized for expertise in biomarker strategy and leading cross-functional teams. Previously, they held director-level positions at Janssen and Bristol Myers Squibb, and have developed novel cancer research models at Exelixis and Pfizer. Kaplan earned a Bachelor of Arts in Biochemistry from Harvard University and a Ph.D. in Biophysics from the University of California, San Francisco.
Location
Westfield, United States
This person is not in any teams